CRI market research report

Blood Grouping Reagents Market Research Report- Forecast till 2027

$4950 – $7250

Blood Grouping Reagents Market Research Report: Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2027

SKU: MRFR220254 Category: Tag:

Description

Blood Grouping Reagents Market Research Report- Forecast till 2027

Market Dynamics
Global Blood Grouping Reagents Market size is expected to register a healthy market growth at significant CAGR of 7.74% during the forecast period to reach USD 2,642.17 million by 2027. The expanding number of blood grouping diagnostics and the rising populace has spurred the interest for robotized blood grouping gadgets.

The completely robotized frameworks can perform many tests in a solitary info, further expanding usefulness and proficiency inside the specified course of events.

Also, the market players are offering completely robotized blood composing gadgets with remote access highlights for upgraded checking and result approval. What’s more, this hardware has explicit highlights of cylinder size and measurement acknowledgment, incorporated quality control program, arbitrary situation for tests, continuous data about the reagent and test status, and superior quality shading results, among others.

The global blood grouping reagents market is expected to register a significant was valued at USD 1,578.78 million in 2020. The market growth is attributed to the rising incidences of chronic disorders and increasing expenditure in medical research. However, concern related to accuracy and efficacy of test kits restrain the growth of the global market.

Market Segmentation
Global Blood Grouping Reagents Market is classified based on Product, Technique, end-user and Test type.

By Product the global market is divided into Consumables and Instruments. The instruments segment is further bifurcated as Fully automated and Semi-automated.

Based on Technique used the market is categorized as PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, and other techniques. The Serology segment is further classified as Gel Technique, Erythrocytes Magnetised Technology (EMT), Solid-Phase Red-Cell Adherence (SPRCA), Glass Slide and Tubes, Cassette/Kit, and Others.

By Test Type the global market is segmented into Blood Group and Phenotype, Antibody Screening, Cross-matching Tests, Antibody Identification, Coombs Tests and Antigen Typing. By end-user the Global Blood Grouping Reagents Market is sectioned as Hospitals, Blood Banks, and Clinical Laboratories.

Regional Analysis
North America dominated the global blood grouping market because of the existence of major manufacturers, growing incidences of chronic diseases accelerates the need for blood transfusion and organ transplant.

The key factors, for example, presence of significant makers, expanding commonness of persistent illnesses prompting the popularity for blood transfusion and organ relocate, mechanical progressions in the clinical section, and expanding mindfulness among the populace are relied upon to drive market development.

Also, expanding interests in research and cooperative way to deal with work on the innovation for blood grouping in the locale is expected to build the market size over the gauge time frame.

Asia-Pacific presents rewarding open doors for players working in the blood grouping reagents market. The blood grouping reagents market in Asia-Pacific is relied upon to be the quickest developing provincial market. Expanding interest for blood banking administrations, government drives and expanding public mindfulness about blood gift are driving the business sectors development around here.

Major Players
The major players of the global blood grouping reagents market are Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), ovacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France), Yuvraj Biobiz Incubator India Pvt (India), Tulip Diagnostics (India), and Aikang (China).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Related Report: Next Generation Blood Gas Monitors System Market : Global Analysis of Market Size, Share & Trends for 2019- 1020 and Forecasts to 2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 2.2 RESEARCH OBJECTIVE 2.3 MARKET STRUCTURE 2.4 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING PREVALENCE OF CHRONIC DISORDERS 4.2.2 INCREASING SPENDING IN MEDICAL RESEARCH 4.3 RESTRAINT 4.3.1 CONCERNS PERTAINING TO THE EFFICIENCY AND ACCURACY OF TEST KITS 4.4 OPPORTUNITY 4.4.1 EMERGENCE OF AUTOMATED BLOOD GROUPING DEVICES 4.5 TECHNOLOGICAL DISRUPTION 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D AND DESIGNING 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION & SALES 5.1.4 POST-SALES REVIEW 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF BUYERS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 5.3.1 IMPACT ON DEMAND 5.3.2 IMPACT ON SUPPLY CHAIN 5.4 VOLUME OF TESTS FOR DONATED BLOOD, BY REGION, 2020 5.5 BLOOD TRANSFUSION VOLUME, BY REGION, 2020 6 GLOBAL BLOOD GROUPING REAGENTS, BY PRODUCT 6.1 OVERVIEW 6.2 CONSUMABLES 6.3 INSTRUMENTS 6.3.1 FULLY-AUTOMATED INSTRUMENTS 6.3.2 SEMI-AUTOMATED INSTRUMENTS 7 GLOBAL BLOOD GROUPING REAGENTS, BY TECHNIQUE 7.1 OVERVIEW 7.2 PCR-BASED AND MICROARRAY TECHNIQUE 7.3 ASSAY-BASED TECHNIQUES 7.4 MASSIVELY PARALLEL SEQUENCING TECHNIQUES 7.5 SEROLOGY 7.5.1 GEL TECHNIQUE 7.5.2 EMT 7.5.3 SPRCA 7.5.4 GLASS SLIDE AND TUBES 7.5.5 CASSETTE/KIT 7.5.6 OTHER SEROLOGY 7.6 OTHER TECHNIQUES 8 GLOBAL BLOOD GROUPING REAGENTS, BY TEST TYPE 8.1 OVERVIEW 8.2 BLOOD GROUP AND PHENOTYPES 8.3 ANTIBODY SCREENING 8.4 CROSSMATCHING TESTS 8.5 ANTIBODY IDENTIFICATION 8.6 COOMBS TEST 8.7 ANTIGEN TYPING 9 GLOBAL BLOOD GROUPING REAGENTS, BY END USER 9.1 OVERVIEW 9.2 HOSPITALS 9.3 BLOOD BANKS 9.4 CLINICAL LABORATORIES 10 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY REGION 10.1 OVERVIEW 10.2 NORTH AMERICA 10.2.1 US 10.2.2 CANADA 10.3 EUROPE 10.3.1 GERMANY 10.3.2 UK 10.3.3 FRANCE 10.3.4 SPAIN 10.3.5 ITALY 10.3.6 REST OF EUROPE 10.4 ASIA PACIFIC 10.4.1 CHINA 10.4.2 JAPAN 10.4.3 INDIA 10.4.4 SOUTH KOREA 10.4.5 AUSTRALIA 10.4.6 REST OF ASIA-PACIFIC 10.5 REST OF THE WORLD 10.5.1 MIDDLE EAST 10.5.2 AFRICA 10.5.3 LATIN AMERICA 11 COMPETITIVE LANDSCAPE 11.1 COMPETITIVE OVERVIEW 11.2 MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET 11.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET 11.4 COMPETITIVE BENCHMARKING 11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES 11.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS 11.7 MAJOR PLAYERS FINANCIAL MATRIX 11.7.1 REVENUE OF MAJOR PLAYERS, 2020 11.7.2 R&D EXPENDITURE 12 COMPANY PROFILES 12.1 MERCK KGAA 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 PRODUCTS OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 BIO-RAD LABORATORIES, INC. 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 SWOT ANALYSIS 12.2.6 KEY STRATEGIES 12.3 NOVACYT GROUP 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCTS/SERVICES OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 KEY STRATEGIES 12.4 BECKMAN COULTER, INC. 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 KEY STRATEGIES 12.5 HAEMOKINESIS PTY LTD 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 KEY STRATEGIES 12.6 MTC MED. PRODUKTE GMBH 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS/SERVICES OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 KEY STRATEGIES 12.7 DAY MEDICAL SA 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 KEY STRATEGIES 12.8 RAPID LABS LTD 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 KEY STRATEGIES 12.9 ORTHO CLINICAL DIAGNOSTICS 12.9.1 COMPANY OVERVIEW 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 SWOT ANALYSIS 12.9.6 KEY STRATEGIES 12.10 DIAGAST SAS 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS/SERVICES OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 KEY STRATEGIES 12.11 GRIFOLS SA 12.11.1 COMPANY OVERVIEW 12.11.2 FINANCIAL OVERVIEW 12.11.3 PRODUCTS/SERVICES OFFERED 12.11.4 KEY DEVELOPMENTS 12.11.5 SWOT ANALYSIS 12.11.6 KEY STRATEGIES 12.12 IMMUCOR, INC. 12.12.1 COMPANY OVERVIEW 12.12.2 FINANCIAL OVERVIEW 12.12.3 PRODUCTS/SERVICES OFFERED 12.12.4 KEY DEVELOPMENTS 12.12.5 SWOT ANALYSIS 12.12.6 KEY STRATEGIES 12.13 QUOTIENT LTD 12.13.1 COMPANY OVERVIEWS 12.13.2 FINANCIAL OVERVIEW 12.13.3 PRODUCTS/SERVICES OFFERED 12.13.4 KEY DEVELOPMENTS 12.13.5 SWOT ANALYSIS 12.13.6 KEY STRATEGIES 12.14 YUVRAJ BIOBIZ INCUBATOR INDIA PVT LTD 12.14.1 COMPANY OVERVIEW 12.14.2 FINANCIAL OVERVIEW 12.14.3 PRODUCTS/SERVICES OFFERED 12.14.4 KEY DEVELOPMENTS 12.14.5 KEY STRATEGIES 12.15 TULIP DIAGNOSTICS 12.15.1 COMPANY OVERVIEW 12.15.2 FINANCIAL OVERVIEW 12.15.3 PRODUCTS/SERVICES OFFERED 12.15.4 KEY DEVELOPMENTS 12.15.5 KEY STRATEGIES 12.16 AIKANG 12.16.1 COMPANY OVERVIEW 12.16.2 FINANCIAL OVERVIEW 12.16.3 PRODUCTS/SERVICES OFFERED 12.16.4 KEY DEVELOPMENTS 12.16.5 KEY STRATEGIES 12.17 INTEC 12.17.1 COMPANY OVERVIEW 12.17.2 FINANCIAL OVERVIEW 12.17.3 PRODUCTS OFFERED 12.17.4 KEY DEVELOPMENTS 12.17.5 KEY STRATEGIES 13 APPENDIX 13.1 REFERENCES 13.2 RELATED REPORTS

Companies Mentioned

Merck KGaA (Germany) Bio-Rad Laboratories Inc (US) ovacyt Group (France) Beckman Coulter Inc (US) Haemokinesis Pty Ltd (Australia) MTC Med. Produkte GmbH (Germany) DAY medical SA (Switzerland) Rapid Labs Ltd (UK) Ortho Clinical Diagnostics (US) Diagast SAS (France) Yuvraj Biobiz Incubator India Pvt (India) Tulip Diagnostics (India) Aikang (China).

Reviews

There are no reviews yet.

Be the first to review “Blood Grouping Reagents Market Research Report- Forecast till 2027”

Related products